Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Common-Size Balance Sheet: Assets 
Quarterly Data

Allergan PLC, common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Cash and cash equivalents 1.13 2.64 1.31 1.73 0.80 0.86 1.11 1.54 0.89 1.54 1.36 0.71 0.86 1.34 5.26 0.37 1.66 0.81 1.45 1.10 1.52
Marketable securities 1.83 3.60 3.51 0.34 1.02 1.01 0.02 0.02 0.93 3.91 3.22 3.96 6.20 8.92 13.81 0.01 0.01 0.01 0.00 0.01 0.01
Accounts receivable, net of allowances for doubtful accounts and credit losses 3.17 3.37 3.19 3.23 2.79 2.82 2.65 2.54 2.36 2.45 2.36 2.24 2.00 1.96 1.67 1.88 1.95 1.77 1.50 3.19 2.86
Inventories 1.36 1.20 1.15 1.05 0.96 0.83 0.84 0.85 0.85 0.76 0.76 0.75 0.71 0.56 0.49 0.55 0.75 0.74 0.90 2.01 2.24
Current assets held for sale 0.00 0.00 0.00 0.00 0.05 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 3.20 2.58 2.61 2.66 0.03 0.10
Prepaid expenses and other current assets 0.97 0.94 1.00 2.63 0.80 0.80 0.75 0.67 0.69 0.95 0.81 0.70 1.03 1.07 0.54 0.59 0.47 0.41 0.52 0.73 0.73
Deferred tax assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.63 0.51 0.43
Current assets 8.45% 11.75% 10.16% 8.98% 6.42% 6.36% 5.39% 5.61% 5.71% 9.61% 8.50% 8.36% 10.80% 13.84% 22.09% 6.60% 7.42% 6.34% 11.66% 7.58% 7.90%
Property, plant and equipment, net 2.17 2.03 1.97 1.91 1.82 1.76 1.65 1.62 1.58 1.51 1.51 1.40 1.31 1.25 1.09 1.17 1.18 1.16 1.10 2.07 2.01
Right of use asset, operating leases 0.54 0.52 0.51 0.48 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments and other assets 0.49 0.43 0.39 0.35 2.02 1.94 0.28 0.27 0.24 0.23 0.23 0.23 0.22 0.22 0.24 0.27 0.30 0.43 0.35 0.38 0.37
Non current assets held for sale 0.04 0.03 0.03 0.03 0.92 0.87 0.16 0.17 0.06 0.07 0.01 0.01 0.02 0.02 0.14 8.14 7.82 7.76 7.40 0.00 0.00
Deferred tax assets 0.68 0.61 0.52 0.72 1.05 1.05 0.93 0.83 0.80 0.27 0.27 0.23 0.20 0.18 0.08 0.14 0.06 0.04 0.05 0.08 0.07
Product rights and other intangibles 41.01 40.01 41.87 43.18 43.11 42.93 45.17 45.87 46.93 46.18 47.65 50.00 49.67 48.55 43.89 48.61 48.90 50.01 47.01 52.61 53.21
Goodwill 46.63 44.61 44.56 44.34 44.20 45.11 46.42 45.64 44.69 42.13 41.83 39.76 37.78 35.94 32.47 35.07 34.34 34.27 32.43 37.28 36.44
Non current assets 91.55% 88.25% 89.84% 91.02% 93.58% 93.64% 94.61% 94.39% 94.29% 90.39% 91.50% 91.64% 89.20% 86.16% 77.91% 93.40% 92.58% 93.66% 88.34% 92.42% 92.10%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC current assets as a percentage of total assets increased from Q3 2019 to Q4 2019 but then decreased significantly from Q4 2019 to Q1 2020.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Allergan PLC property, plant and equipment, net as a percentage of total assets increased from Q3 2019 to Q4 2019 and from Q4 2019 to Q1 2020.
Non current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan PLC non current assets as a percentage of total assets decreased from Q3 2019 to Q4 2019 but then increased from Q4 2019 to Q1 2020 exceeding Q3 2019 level.